influenza endonuclease inhibitors (Cocrystal Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameinfluenza endonuclease inhibitors (Cocrystal Pharma)
Drug Alias Namebroad-spectrum antivirals (Biozone/Cocrystal)broad-spectrum antivirals (Cocrystal Discovery)broad-spectrum antivirals (Cocrystal Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndonucleases inhibitors
TargetsEndonucleases
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCocrystal Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCocrystal Discovery IncCocrystal Pharma Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A